Patents by Inventor Edwin Curran Murphy, III

Edwin Curran Murphy, III has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Injectable meclizine formulations and methods
    Patent number: 8293749
    Abstract: Methods of treating or preventing a vertigo, nausea, or vomiting condition comprising injecting a subject with a pharmaceutically acceptable formulation consisting essentially of an effective amount of meclizine or a pharmaceutically acceptable salt thereof, a chemically modified cyclodextrin, and an aqueous carrier medium having a pH between about 2 and about 7 are disclosed. An injectable pharmaceutical formulation for treating or preventing a vertigo, nausea, or vomiting condition consisting essentially of an effective amount of meclizine, a chemically modified cyclodextrin, and an aqueous carrier medium having a pH between about 2 and about 7 is also disclosed.
    Type: Grant
    Filed: January 12, 2012
    Date of Patent: October 23, 2012
    Assignee: Genebiology, Inc.
    Inventors: Walker Anderson Long, Edwin Curran Murphy, III
  • INJECTABLE MECLIZINE FORMULATIONS AND METHODS
    Publication number: 20120108608
    Abstract: Methods of treating or preventing a vertigo, nausea, or vomiting condition comprising injecting a subject with a pharmaceutically acceptable formulation consisting essentially of an effective amount of meclizine or a pharmaceutically acceptable salt thereof, a chemically modified cyclodextrin, and an aqueous carrier medium having a pH between about 2 and about 7 are disclosed. An injectable pharmaceutical formulation for treating or preventing a vertigo, nausea, or vomiting condition consisting essentially of an effective amount of meclizine, a chemically modified cyclodextrin, and an aqueous carrier medium having a pH between about 2 and about 7 is also disclosed.
    Type: Application
    Filed: January 12, 2012
    Publication date: May 3, 2012
    Inventors: WALKER ANDERSON LONG, EDWIN CURRAN MURPHY, III
  • Injectable meclizine formulations and methods
    Patent number: 8138192
    Abstract: Methods of treating or preventing a vertigo, nausea, or vomiting condition comprising injecting a subject with a pharmaceutically acceptable formulation consisting essentially of an effective amount of meclizine or a pharmaceutically acceptable salt thereof, a chemically modified cyclodextrin, and an aqueous carrier medium having a pH between about 2 and about 7 are disclosed. An injectable pharmaceutical formulation for treating or preventing a vertigo, nausea, or vomiting condition consisting essentially of an effective amount of meclizine, a chemically modified cyclodextrin, and an aqueous carrier medium having a pH between about 2 and about 7 is also disclosed.
    Type: Grant
    Filed: October 31, 2007
    Date of Patent: March 20, 2012
    Assignee: Genebiology, Inc.
    Inventors: Walker Anderson Long, Edwin Curran Murphy, III
  • Injectable meclizine formulations and methods
    Publication number: 20090111833
    Abstract: Methods of treating or preventing a vertigo, nausea, or vomiting condition comprising injecting a subject with a pharmaceutically acceptable formulation consisting essentially of an effective amount of meclizine or a pharmaceutically acceptable salt thereof, a chemically modified cyclodextrin, and an aqueous carrier medium having a pH between about 2 and about 7 are disclosed. An injectable pharmaceutical formulation for treating or preventing a vertigo, nausea, or vomiting condition consisting essentially of an effective amount of meclizine, a chemically modified cyclodextrin, and an aqueous carrier medium having a pH between about 2 and about 7 is also disclosed.
    Type: Application
    Filed: October 31, 2007
    Publication date: April 30, 2009
    Inventors: Walker Anderson LONG, Edwin Curran MURPHY, III